SCHEMBL7207237

SCHEMBL7207237

CN1CC(NC(=O)CCC2CCCCC2)N=C(c2ccccc2)c2ccccc21

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.69
ALDH1A1 P00352 2/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
CCKBR P32239 3/20 0.48
CCKAR P32238 1/20 0.48
PSEN1 P49768 1/20 0.48
PSEN2 P49810 1/20 0.48
APH1B Q8WW43 1/20 0.48
NCSTN Q92542 1/20 0.48
APH1A Q96BI3 1/20 0.48
PSENEN Q9NZ42 1/20 0.48
HTT P42858 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
OXTR P30559 1/20 0.46
HDAC3 O15379 8/20 0.46
HDAC1 Q13547 8/20 0.46
HDAC8 Q9BY41 8/20 0.46
HDAC6 Q9UBN7 8/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27532959 0.88 KCNH2 (0.57) KCNH2ALDH1A1MEN1KMT2ATDP1
SCHEMBL27509059 0.82 PSEN1 (0.50) KCNH2CCKBRCCKARPSEN1PSEN2
SCHEMBL7090700 0.82 KCNH2 (1.00) KCNH2CCKBRCCKARPSEN1PSEN2
SCHEMBL7087129 0.82 KCNH2 (1.00) KCNH2CCKBRCCKARPSEN1PSEN2
SCHEMBL7090513 0.81 KCNH2 (0.81) KCNH2CCKBRCCKARPSEN1PSEN2
SCHEMBL27568925 0.81 PSEN1 (0.49) KCNH2CCKBRCCKARPSEN1PSEN2
SCHEMBL8761589 0.79 KCNH2 (0.80) KCNH2CCKBRCCKARPSEN1PSEN2
SCHEMBL8760297 0.77 KCNH2 (0.78) KCNH2CCKBRCCKARPSEN1PSEN2
SCHEMBL8761581 0.77 KCNH2 (0.78) KCNH2CCKBRCCKARPSEN1PSEN2
SCHEMBL27528237 0.77 KCNH2 (0.52) KCNH2CCKBRCCKARPSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0907644-A4 PHARMACEUTICAL PREPARATION MERCK & CO INC (US) 2003-02-05 EP disclosed
EP-0907644-A1 PHARMACEUTICAL PREPARATION Merck & Co., Inc. (US) 1999-04-14 EP disclosed
US-5817658-A ADMINISTERING A DIAZEPINE COMPOUND; DISEASES OF THE EAR MERCK & COMPANY, INC. (US) 1998-10-06 US disclosed
US-5776930-A CARDIOVASCULAR DISORDERS MERCK & COMPANY, INC. (US) 1998-07-07 US disclosed
EP-0730453-A4 METHODS OF TREATING CARDIAC ARRHYTHMIA MERCK & CO INC (US) 1998-03-04 EP disclosed
WO-1998000405-A1 PHARMACEUTICAL PREPARATION MERCK & CO., INC. (US) 1998-01-08 WO disclosed
US-5597818-A CARDIOVASCULAR DISORDERS MERCK & CO., INC. (US) 1997-01-28 US disclosed
US-5595990-A TREATMENT OF CARDIOVASCULAR DISORDERS MERCK & CO., INC. (US) 1997-01-21 US disclosed
EP-0730453-A1 METHODS OF TREATING CARDIAC ARRHYTHMIA MERCK & CO. INC. (US) 1996-09-11 EP disclosed
US-5428031-A Benzodiazepine analogs; cardiovascular disorders MERCK & CO., INC. (US) 1995-06-27 US disclosed
US-5426185-A Antiarrhythmia agents having reduced side effects MERCK & CO., INC. (US) 1995-06-20 US disclosed
WO-1995014471-A1 ANTIARRHYTHMIC BENZODIAZEPINES MERCK & CO., INC. (US) 1995-06-01 WO disclosed
WO-1995014470-A1 METHODS OF TREATING CARDIAC ARRHYTHMIA MERCK & CO., INC. (US) 1995-06-01 WO disclosed